Trials / Completed
CompletedNCT02539849
Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease
Effect of Prebiotic Fructo-oligosaccharides (FOS) on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
FOS improve gut colonization by Faecalibacterium prausnitzii in patients with Crohn's disease
Detailed description
To demonstrate that FOS increases counts of Faecalibacterium prausnitzii in faecal samples from Crohn's disease patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | FOS | |
| DRUG | Adalimumab |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2017-12-19
- Completion
- 2017-12-19
- First posted
- 2015-09-03
- Last updated
- 2018-01-31
Locations
5 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02539849. Inclusion in this directory is not an endorsement.